Genistein Reduces the Risk of Local Mammary Cancer Recurrence and Ameliorates Alterations in the Gut Microbiota in the Offspring of Obese Dams
The risk of recurrence of estrogen receptor-positive breast cancer remains constant, even 20 years after diagnosis. Recurrence may be more likely in patients pre-programmed for it already in the womb, such as in the daughters born to obese mothers. Maternal obesity persistently alters offspring’s gu...
Main Authors: | Fabia de Oliveira Andrade, Fang Liu, Xiyuan Zhang, Mariana Papaleo Rosim, Caroline Dani, Idalia Cruz, Thomas T. Y. Wang, William Helferich, Robert W. Li, Leena Hilakivi-Clarke |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/13/1/201 |
Similar Items
-
Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer
by: Li Yuanyuan, et al.
Published: (2013-02-01) -
Younger tamoxifen-treated breast cancer patients also had higher risk of endometrial cancer and the risk could be reduced by sequenced aromatase inhibitor use: A population-based study in Taiwan
by: Sung-Chao Chu, et al.
Published: (2020-01-01) -
Poly-ADP-Ribosylation of Estrogen Receptor-Alpha by PARP1 Mediates Antiestrogen Resistance in Human Breast Cancer Cells
by: Nicholas Pulliam, et al.
Published: (2019-01-01) -
Dietary genistein stimulates mammary hyperplasia in gilts
by: C. Farmer, et al.
Published: (2010-01-01) -
Abrogating endocrine resistance by targeting ER alpha and PI3K in breast cancer
by: Emily M Fox, et al.
Published: (2012-10-01)